1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow IBI356 for MAD: new trials by email Literature Review of IBI356 for MAD trials Research Report on IBI356 for MAD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A First In Human (FIH) Study of IBI356 in Healthy Participants and in Atopic Dermatitis Patients IBI356 for MAD, Dupilumab for MAD, IBI356 for SAD - Healthy Participants, Atopic Dermatitis Patients | Phase 1 | Completed | Innovent Biologics (Suzhou) Co. Ltd. | 99 | 2024-01-05 | 2025-09-02 |
Innovent Biologics (Suzhou) Co. Ltd. (1)
China (1)